UA
50
-9
VFC
53
5
CSX
60
3
AVY
53
3
GOOG
50
-3
CINF
53
2
COF
60
2
NDAQ
62
2
NKE
36
6
SLB
55
2
BF.B
33
2
EBAY
47
4
TXT
55
3
PSX
47
2
BWA
48
2
NEE
50
-5
CMG
72
5
ADBE
49
3
CFG
70
6
GS
75
2
UA
50
-9
VFC
53
5
CSX
60
3
AVY
53
3
GOOG
50
-3
CINF
53
2
COF
60
2
NDAQ
62
2
NKE
36
6
SLB
55
2
BF.B
33
2
EBAY
47
4
TXT
55
3
PSX
47
2
BWA
48
2
NEE
50
-5
CMG
72
5
ADBE
49
3
CFG
70
6
GS
75
2
Financhill
Back

Ikena Oncology Vs. iBio Industry Stock Comparison

Sell
36

IKNA
Ikena Oncology

Last Price:
1.69
Seasonality Move:
7.58%
Sell
43

IBIO
iBio

Last Price:
2.64
Seasonality Move:
-5.06%
Sell
36
Ikena Oncology (IKNA) is a Sell

Is Ikena Oncology a Buy, Sell or Hold?

  • The current Ikena Oncology [IKNA] share price is $1.71. The Score for IKNA is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • IKNA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
iBio (IBIO) is a Sell

Is iBio a Buy, Sell or Hold?

  • The current iBio [IBIO] share price is $2.64. The Score for IBIO is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • IBIO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

IKNA Stock Price Chart

What is Ikena Oncology's stock price today?

  • The Ikena Oncology share price today is $1.71
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IKNA is experiencing slight buying pressure.

IBIO Stock Price Chart

What is iBio's stock price today?

  • The iBio share price today is $2.64
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IBIO is experiencing slight buying pressure.

IKNA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 49.84 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.69 - 1.73) Sell
Bollinger Bands (100): (1.67 - 1.73) Buy

IBIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 56.35 Buy
Chaikin Money Flow: 23623 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.34 - 2.82) Buy
Bollinger Bands (100): (1.86 - 2.56) Buy

IKNA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.7 Buy
20-day SMA: 1.71 Sell
50-day SMA: 1.71 Buy
200-day SMA: 1.58 Buy
8-day EMA: 1.71 Buy
20-day EMA: 1.71 Sell
50-day EMA: 1.71 Buy
200-day EMA: 1.88 Sell

IBIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.31 Buy
20-day SMA: 2.51 Buy
50-day SMA: 2.43 Buy
200-day SMA: 2.03 Buy
8-day EMA: 2.4 Buy
20-day EMA: 2.46 Buy
50-day EMA: 2.41 Buy
200-day EMA: 3.88 Sell

Ikena Oncology Earnings Growth & IKNA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.66 per share, and an increase next year of $0.08 per share.

iBio Earnings Growth & IBIO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $103.99 per share, and an increase next year of $5.67 per share.

Ikena Oncology Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

iBio Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):